Latest news
Axsome Therapeutics Q2 2026 Earnings Call Transcript - MarketBeatMarketBeat · Mon, 10 Aug 2026 14:37:56 GMTAxsome Therapeutics Q2 Earnings Call Highlights - MarketBeatMarketBeat · Mon, 10 Aug 2026 13:19:46 GMTAxsome Therapeutics (NASDAQ:AXSM) Issues Quarterly Earnings Results - MarketBeatMarketBeat · Mon, 10 Aug 2026 11:41:44 GMTHennion & Walsh Asset Management Inc. Sells 19,128 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeatMarketBeat · Mon, 10 Aug 2026 09:45:19 GMTInsider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $9,541,298.04 in Stock - MarketBeatMarketBeat · Fri, 07 Aug 2026 23:12:41 GMTAxsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 4,660 Shares - MarketBeatMarketBeat · Fri, 07 Aug 2026 23:12:40 GMTCalifornia State Teachers Retirement System Grows Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeatMarketBeat · Thu, 06 Aug 2026 10:22:26 GMTEmpowered Funds LLC Grows Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeatMarketBeat · Tue, 04 Aug 2026 08:44:01 GMT